DDW 2022 Conference Coverage
Playback speed
10 seconds
Early Experience of Ustekinumab for Treatment of Moderate-To-Severe Inflammatory Bowel Disease in Patients Post-Liver Transplant
By
DDW 2022 Conference Coverage
FEATURING
Pooja Magavi
By
DDW 2022 Conference Coverage
FEATURING
Pooja Magavi
11 views
July 8, 2022
Login to view comments.
Click here to Login
Videos